Pharmacology Update 2021 live until March 25th featuring Michael Fingerhood, MD - My favorite new patient: The triad of untreated HIV, hepatitis C and opioid use disorder

As MAAPC takes a break from our educational goals, we continue to focus on the future of our APN profession in Maryland by assisting our CNS and CRNP colleagues in obtaining prescriptive authority. For more information, please visit MAAPC/Legislative Platform 2022 and CBANACNS/ CNS Prescriptive Authority.

Register now for Pharmacology Update 2021

Michael Fingerhood has been promoting and improving the provision of medical care to patients with substance use disorder, including the treatment of HIV and hepatitis C, with the development, maintenance and evaluation of innovative programs related to the care of these individuals. I created the Comprehensive Care Practice in 1994, a primary care practice largely devoted to providing care to individuals with substance use disorder. The practice has been innovative in integrating buprenorphine treatment into the primary care setting for over 650 individuals. I also co-created novel buprenorphine treatment programs at a community center, at a church and in a mobile van outside the Baltimore detention center. I have received the Health Equity Leadership award from the Baltimore City Health Department and co-author of the ASAM Handbook of Addiction Medicine. I have co-authored over 60 research papers and had received NIH research funding continuously over the past 30 years.

A thank you to our Industry and Pharmaceutical partners who continue to provide us with up-to-date information, new products, and practice information (Click for more information).